In This Article:
Raymond James tells investors in a research note that it would take $40-$50 per share for private equity to take Acadia Healthcare (ACHC) private for a deal to make sense, but that anything over $50 “wouldn’t imply enough return” for it to make sense. The firm, which has a Strong Buy rating on Acadia shares, thinks it is becoming increasingly likely that a take private scenario occurs as the stock has floundered in the public market amid legal trouble and struggling fundamentals.
Light Up your Portfolio with Spark:
-
Easily identify stocks' risks and opportunities.
-
Discover stocks' market position with detailed competitor analyses.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ACHC:
Disclaimer & DisclosureReport an Issue
-
Acadia Healthcare price target lowered to $37 from $48 at Mizuho
-
Acadia Healthcare price target lowered to $44 from $66 at TD Cowen
-
Acadia Healthcare price target lowered to $43 from $64 at RBC Capital
-
Acadia Healthcare price target lowered to $65 from $70 at KeyBanc
-
Strategic Growth Amidst Challenges: Whit Mayo’s Buy Rating on Acadia Healthcare